117 related articles for article (PubMed ID: 38023249)
1. Corrigendum: Development and validation of a m
Chen Y; Xia L; Peng Y; Wang G; Bi L; Xiao X; Li C; Li W
Front Oncol; 2023; 13():1309950. PubMed ID: 38023249
[TBL] [Abstract][Full Text] [Related]
2. Corrigendum: Comprehensive analysis of the transcriptome-wide m6A methylome in lung adenocarcinoma by MeRIP sequencing.
Mao W; Yu Q; Wang K; Ma Q; Zheng Y; Zhang G; Luo W; Wang N; Wang Y
Front Oncol; 2022; 12():1032295. PubMed ID: 36267960
[TBL] [Abstract][Full Text] [Related]
3. Development and validation of a m
Chen Y; Xia L; Peng Y; Wang G; Bi L; Xiao X; Li C; Li W
Front Oncol; 2022; 12():947808. PubMed ID: 36303829
[TBL] [Abstract][Full Text] [Related]
4. Corrigendum: Identification and Validation Prognostic Impact of miRNA-30a-5p in Lung Adenocarcinoma.
Jiang X; Yuan Y; Tang L; Wang J; Zhang D; Cho WC; Duan L
Front Oncol; 2022; 12():862076. PubMed ID: 35280792
[TBL] [Abstract][Full Text] [Related]
5. Corrigendum: identification and validation of lncRNA-SNHG17 in lung adenocarcinoma: a novel prognostic and diagnostic indicator.
Li X; Yuan Y; Pal M; Jiang X
Front Oncol; 2022; 12():972329. PubMed ID: 35957918
[TBL] [Abstract][Full Text] [Related]
6. Corrigendum: The m6A methyltransferase METTL16 inhibits the proliferation of pancreatic adenocarcinoma cancer cells via the p21 signaling pathway.
Xie F; Zheng Y; Fu W; Chi B; Wang X; Zhang J; Gu J; Yin J; Zhou Q; Guo S; Cai L; Yang J; Liu S; Wang H
Front Oncol; 2023; 13():1218781. PubMed ID: 37274238
[TBL] [Abstract][Full Text] [Related]
7. Identification of a m
Li D; Chen T; Li QG
BMC Pulm Med; 2023 Apr; 23(1):128. PubMed ID: 37072786
[TBL] [Abstract][Full Text] [Related]
8. Corrigendum: NPM1 Is a Prognostic Biomarker Involved in Immune Infiltration of Lung Adenocarcinoma and Associated With m6A Modification and Glycolysis.
Liu XS; Zhou LM; Yuan LL; Gao Y; Kui XY; Liu XY; Pei ZJ
Front Immunol; 2021; 12():751004. PubMed ID: 34531879
[TBL] [Abstract][Full Text] [Related]
9. A five-m6A regulatory gene signature is a prognostic biomarker in lung adenocarcinoma patients.
Wu X; Sheng H; Wang L; Xia P; Wang Y; Yu L; Lv W; Hu J
Aging (Albany NY); 2021 Mar; 13(7):10034-10057. PubMed ID: 33795529
[TBL] [Abstract][Full Text] [Related]
10. Corrigendum: Comprehensive Analysis of N6-Methylandenosine-Related Long Non-Coding RNAs Signature in Prognosis and Tumor Microenvironment of Bladder Cancer.
Chen K; Zhu S; Yu W; Xia Y; Xing J; Geng J; Cheng F
Front Oncol; 2022; 12():908832. PubMed ID: 35600386
[TBL] [Abstract][Full Text] [Related]
11. Corrigendum: Identification of a Two-Gene (
Liu S; Liu J; Yu X; Shen T; Fu Q
Front Oncol; 2021; 11():671129. PubMed ID: 33937083
[TBL] [Abstract][Full Text] [Related]
12. m6A RNA Methylation Regulators Participate in the Malignant Progression and Have Clinical Prognostic Value in Lung Adenocarcinoma.
Li F; Wang H; Huang H; Zhang L; Wang D; Wan Y
Front Genet; 2020; 11():994. PubMed ID: 33193582
[TBL] [Abstract][Full Text] [Related]
13. Corrigendum: Prognostic Nomograms for Predicting Overall Survival and Cancer-Specific Survival of Patients With Early Onset Colon Adenocarcinoma.
Jin H; Feng Y; Guo K; Ruan S
Front Oncol; 2021; 11():793652. PubMed ID: 35004318
[TBL] [Abstract][Full Text] [Related]
14. Corrigendum: Heparin binding epidermal growth factor-like growth factor is a prognostic marker correlated with levels of macrophages infiltrated in lung adenocarcinoma.
Van Hiep N; Sun WL; Feng PH; Lin CW; Chen KY; Luo CS; Dung LN; Van Quyet H; Wu SM; Lee KY
Front Oncol; 2022; 12():1106553. PubMed ID: 36582792
[TBL] [Abstract][Full Text] [Related]
15. Corrigendum: Long non-coding RNA-TMPO-AS1 as ceRNA binding to let-7c-5p upregulates STRIP2 expression and predicts poor prognosis in lung adenocarcinoma.
Wang J; Yuan Y; Tang L; Zhai H; Zhang D; Duan L; Jiang X; Li C
Front Oncol; 2022; 12():1109637. PubMed ID: 36582796
[TBL] [Abstract][Full Text] [Related]
16. Corrigendum: A Non-invasive Method to Diagnose Lung Adenocarcinoma.
Yan M; Wang W
Front Oncol; 2020; 10():1515. PubMed ID: 32983996
[TBL] [Abstract][Full Text] [Related]
17. Corrigendum: Development and Validation of a Prognostic Nomogram to Predict Cancer-Specific Survival in Adult Patients With Pineoblastoma.
Jing Y; Deng W; Zhang H; Jiang Y; Dong Z; Fan F; Sun P
Front Oncol; 2020; 10():594049. PubMed ID: 33123489
[TBL] [Abstract][Full Text] [Related]
18. Corrigendum: Evaluation of the Stellae-123 prognostic gene expression signature in acute myeloid leukemia.
Mosquera Orgueira A; Peleteiro Raíndo A; Díaz Arias JÁ; Antelo Rodríguez B; López Riñón M; Cerchione C; de la Fuente Burguera A; González Pérez MS; Martinelli G; Montesinos Fernández P; Pérez Encinas MM
Front Oncol; 2023; 13():1302993. PubMed ID: 37860185
[TBL] [Abstract][Full Text] [Related]
19. Corrigendum: Serum Biomarker Panel for Diagnosis and Prognosis of Pancreatic Ductal Adenocarcinomas.
Mehta S; Bhimani N; Gill AJ; Samra JS; Sahni S; Mittal A
Front Oncol; 2021; 11():774861. PubMed ID: 34692555
[TBL] [Abstract][Full Text] [Related]
20. A Novel M6A-Related Genes Signature Can Impact the Immune Status and Predict the Prognosis and Drug Sensitivity of Lung Adenocarcinoma.
Wang X; Zhao C; Huang D; Liu Z; Liu M; Lin F; Lu Y; Jia J; Lin L; Lin X; Li H; Chen Z
Front Immunol; 2022; 13():923533. PubMed ID: 35860262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
